Post-COVID-19 Monitoring in Routine Health Insurance Data

CompletedOBSERVATIONAL
Enrollment

157,134

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Virus DiseasesEpidemiology
Interventions
OTHER

Exposed to a SARS-CoV-2 infection

The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.

Trial Locations (1)

01307

Center for Evidence-Based Healthcare, Dresden

All Listed Sponsors
collaborator

InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH

UNKNOWN

collaborator

BARMER Institut für Gesundheitssystemforschung (bifg)

UNKNOWN

collaborator

AOK Bayern

INDUSTRY

collaborator

AOK PLUS

INDUSTRY

collaborator

DAK Gesundheit

OTHER

collaborator

Techniker Krankenkasse

OTHER

lead

Technische Universität Dresden

OTHER

NCT05074953 - Post-COVID-19 Monitoring in Routine Health Insurance Data | Biotech Hunter | Biotech Hunter